RU2002109353A - Method for lymphotropic therapy of patients with open-angle glaucoma with normalized intraocular pressure - Google Patents
Method for lymphotropic therapy of patients with open-angle glaucoma with normalized intraocular pressureInfo
- Publication number
- RU2002109353A RU2002109353A RU2002109353/14A RU2002109353A RU2002109353A RU 2002109353 A RU2002109353 A RU 2002109353A RU 2002109353/14 A RU2002109353/14 A RU 2002109353/14A RU 2002109353 A RU2002109353 A RU 2002109353A RU 2002109353 A RU2002109353 A RU 2002109353A
- Authority
- RU
- Russia
- Prior art keywords
- open
- intraocular pressure
- patients
- angle glaucoma
- normalized
- Prior art date
Links
- 206010030348 Open-Angle Glaucoma Diseases 0.000 title claims 2
- 230000004410 intraocular pressure Effects 0.000 title claims 2
- 238000000034 method Methods 0.000 title claims 2
- 238000002560 therapeutic procedure Methods 0.000 title 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- JPGDYIGSCHWQCC-UHFFFAOYSA-N emoxypine Chemical compound CCC1=NC(C)=CC=C1O JPGDYIGSCHWQCC-UHFFFAOYSA-N 0.000 claims 1
- 229960002897 heparin Drugs 0.000 claims 1
- 229920000669 heparin Polymers 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 210000001595 mastoid Anatomy 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
- 230000004304 visual acuity Effects 0.000 claims 1
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2002109353/14A RU2212211C1 (en) | 2002-04-10 | 2002-04-10 | Lymphotropic therapy method for treating patients for open angle glaucoma with normalized intraocular pressure |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2002109353/14A RU2212211C1 (en) | 2002-04-10 | 2002-04-10 | Lymphotropic therapy method for treating patients for open angle glaucoma with normalized intraocular pressure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2212211C1 RU2212211C1 (en) | 2003-09-20 |
| RU2002109353A true RU2002109353A (en) | 2003-12-20 |
Family
ID=29777637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2002109353/14A RU2212211C1 (en) | 2002-04-10 | 2002-04-10 | Lymphotropic therapy method for treating patients for open angle glaucoma with normalized intraocular pressure |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2212211C1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2284192C1 (en) * | 2005-04-01 | 2006-09-27 | Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова Министерства здравоохранения РФ | Method for treatment of glaucoma optical neuropathy |
| RU2508920C1 (en) * | 2012-10-08 | 2014-03-10 | Общество с Ограниченной Ответственностью "Медицинский центр "Светоч" | Method of treating dystrophic and inflammatory diseases of anterior and posterior segment of eyeball |
-
2002
- 2002-04-10 RU RU2002109353/14A patent/RU2212211C1/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1152651C (en) | Open angle glaucoma treatment apparatus and method | |
| ATE339170T1 (en) | DEVICE FOR RELEASING AN OPHTHALMIC MEDICINAL PRODUCT | |
| ATE493981T1 (en) | ONCE DAILY DOSAGE FORMS OF TROSPIUM | |
| WO2000056354A3 (en) | Methods of using agents that act on the epithelial sheet of a human eye | |
| AR016798A1 (en) | USE OF A LACTOBACILLUS CEPA FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
| RU2002109353A (en) | Method for lymphotropic therapy of patients with open-angle glaucoma with normalized intraocular pressure | |
| RU2002117537A (en) | A method for treating the effects of tissue hypoxia in critically ill patients | |
| RU2000101091A (en) | METHOD FOR TREATING DYSTROPHIC DISEASES OF THE RETAIL AND VISUAL NERVE | |
| MX2009005503A (en) | Use of l-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases. | |
| WO2005087255A3 (en) | Method of optimizing treatment with interferon-tau | |
| ATE345805T1 (en) | CALCIUM TRIFLUOROCETATE WITH CYTOTOXIC EFFECT | |
| WO2005058248A3 (en) | A method of treating hiv infection in atazanavir resistant patients using a combination of atazanavir and another protease inhibitor | |
| LeBlanc et al. | Timolol: long-term Canadian multicentre study | |
| Makashova | INFLUENCE OF MEDICAL THERAPY ON VISUAL FUNCTIONS HYDRODYNAMICS AND BLOOD-FLOW IN THE OPTIC NERVE IN PATIENTS WITH GLAUCOMA IN COMBINATION WITH MYOPIA | |
| RU94000695A (en) | Agent showing antiallergic action | |
| EP1629843A3 (en) | Reboxetine for treating chronic fatigue syndrome | |
| RU2000114395A (en) | METHOD FOR TREATING A SMALL FRONT ANCIENT SYNDROME OR VASCULAR DEFLECTION AFTER ANTIGLAUCOMATIC OPERATIONS | |
| MX2025003110A (en) | Treating hiv with cabotegravir and rilpivirine in pediatric patients | |
| Goldberg | Comparison of tropical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension. J. Glaucoma 2001; 10: 414-22 | |
| Bessmertny et al. | COMBINED TREATMENT OF NEOVASCU-LAR GLAUCOMA | |
| WO2024254377A3 (en) | Methods of treating lipedema and lymphatic disease of the subcutaneous tissue | |
| UA40487A (en) | METHOD OF SURGICAL TREATMENT OF PATIENTS WITH FOREIGN BODIES LOCALIZED IN THE "BORDER ZONE" OF THE EYE AND RETACHMENT OF THE RETINAL | |
| RU2001132588A (en) | New Use of Substances for PMS | |
| RU2000118509A (en) | A method for the treatment of neovasculogenesis after end-to-end keratoplasty | |
| Gogia et al. | TOPICALLY EFFECTIVE OPHTHALMIC SOLUTION OF ACETAZOLAMIDE-FU-TURE PERSPECTIVE IN ANTI-GLAUCOMA THERAPY |